Immune Checkpoint Inhibitor Clinical Trials in Zhengzhou, Henan
2 recruitingZhengzhou, Henan, China
Showing 1–2 of 2 trials
Recruiting
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
Lung CancerVenous ThromboembolismArterial Thromboembolism+1 more
Beijing Chao Yang Hospital2,400 enrolled5 locationsNCT06950697
Recruiting
Phase 2
Toripalimab Plus FLOT in Locally Advanced Gastric Cancer
ChemotherapyLocally Advanced Gastric CarcinomaImmune Checkpoint Inhibitor
Henan Cancer Hospital60 enrolled1 locationNCT04891016